NCT06225050 - M-2018-334 in Hematological Malignancies | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2028

Conditions

Hematological Malignancies

Interventions

DEVICE

CliniMACS Prodigy® LP-TCRα/β-19-45RA (Trial Version)

PBSC grafts from haploidentical donors depleted of TCRaβ+ cells and CD45RA+ cells using CliniMACS Prodigy® will be infused into patients intravenously (IV)